Variants which were discovered in 2 or more MS probands were evaluated to determine whether their multiple occurrence in our MS cohorts might be significant, considering their relative scarcity in the general population (gnomAD).
← all excerpts
Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes.
1
—
—